日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Intravitreal Povidone-Iodine Injection and Low-Dose Antibiotic Irrigation for Infectious Endophthalmitis: A Retrospective Case Series

玻璃体内注射聚维酮碘联合低剂量抗生素冲洗治疗感染性眼内炎：回顾性病例系列研究

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics17080995
Machida, Yumiko; Nakashizuka, Hiroyuki; Onoe, Hajime; Kitagawa, Yorihisa; Nakagawa, Naoya; Miyata, Keisuke; Yamakawa, Misato; Wakatsuki, Yu; Tanaka, Koji; Mori, Ryusaburo; Shimada, Hiroyuki
炎症/感染
发表日期：2025
文献求助 收藏

Incidence of recurrence and development of polypoidal lesions following half-dose and two-thirds dose photodynamic therapy for pachychoroid neovasculopathy

脉络膜新生血管病患者接受半剂量和三分之二剂量光动力疗法后复发和息肉样病变的发生率

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-03782-2
Tanaka, Koji; Onoe, Hajime; Takeshima, Keigo; Kono, Michiteru; Wakatsuki, Yu; Kawamura, Akiyuki; Mori, Ryusaburo; Nakashizuka, Hiroyuki
发表日期：2025
文献求助 收藏

Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study

Brolucizumab治疗日本新生血管性年龄相关性黄斑变性患者的真实世界疗效：一项为期12个月的多中心研究

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-025-01159-2
Ohnaka, Masayuki; Sakurada, Yoichi; Hayashi, Atsushi; Kadonosono, Kazuaki; Ohno, Hitoshi; Mori, Ryusaburo; Matsumoto, Hidetaka; Nagamori, Ippei; Murata, Yuki; Maio-Twofoot, Tina; Karcher, Helene; Takahashi, Hidenori
发表日期：2025
文献求助 收藏

Phase I Study of Tivozanib Eye Drops in Healthy Volunteers and Patients with Neovascular Age-Related Macular Degeneration

替沃扎尼滴眼液在健康志愿者和新生血管性年龄相关性黄斑变性患者中的I期研究

期刊:Ophthalmology Science
影响因子:4.6
doi:10.1016/j.xops.2024.100553
Gomi, Fumi; Iida, Tomohiro; Mori, Ryusaburo; Horita, Shinya; Nakamura, Hiroaki; Nakajima, Yu; Shiokawa, Ayako; Takahashi, Kanji
发表日期：2024
文献求助 收藏

Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the EVEREST II Study

EVEREST II 研究中息肉状脉络膜血管病变患者的六年随访结果

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-024-00888-0
Teo, Kelvin Yi Chong; Park, Kyu-Hyung; Ngah, Nor Fariza; Chen, Shih-Jen; Ruamviboonsuk, Paisan; Mori, Ryusaburo; Kondo, Nagako; Lee, Won Ki; Rajagopalan, Rajesh; Obata, Ryo; Wong, Ian Y H; Chee, Caroline; Terasaki, Hiroko; Sekiryu, Tetsuju; Chen, Shih-Chou; Yanagi, Yasuo; Honda, Shigeru; Lai, Timothy Y Y; Cheung, Chui Ming Gemmy
REST
发表日期：2024
文献求助 收藏

The Evaluation of Change in Choroidal Circulation Time before and after Half-Dose Photodynamic Therapy in Central Serous Chorioretinopathy Using Wide-Field Indocyanine Green Angiography

采用广角吲哚菁绿血管造影术评估中心性浆液性脉络膜视网膜病变患者接受半剂量光动力疗法前后脉络膜循环时间的变化

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm13144257
Sugiyama, Ruri; Mori, Ryusaburo; Kawamura, Akiyuki; Tanaka, Koji; Onoe, Hajime; Wakatsuki, Yu; Nakashizuka, Hiroyuki
视网膜病变
神经科学
发表日期：2024
文献求助 收藏

Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial

法瑞西单抗治疗新生血管性年龄相关性黄斑变性患者的疗效、持久性和安全性（最长达16周）：来自TNAYA III期临床试验日本亚组的2年结果

期刊:Graefes Archive for Clinical and Experimental Ophthalmology
影响因子:2.3
doi:10.1007/s00417-024-06377-1
Koizumi, Hideki; Gomi, Fumi; Tsujikawa, Akitaka; Honda, Shigeru; Mori, Ryusaburo; Ochi, Haruka; Iwasaki, Keisuke; Okada, Annabelle Ayame
发表日期：2024
文献求助 收藏

Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trial

法瑞西单抗治疗新生血管性年龄相关性黄斑变性患者的疗效、持久性和安全性（最长达16周一次）：来自TENAYA III期临床试验日本亚组的1年结果

期刊:Japanese Journal of Ophthalmology
影响因子:1.9
doi:10.1007/s10384-023-00985-w
Mori, Ryusaburo; Honda, Shigeru; Gomi, Fumi; Tsujikawa, Akitaka; Koizumi, Hideki; Ochi, Haruka; Ohsawa, Shino; Okada, Annabelle Ayame
发表日期：2023
文献求助 收藏

Correction to: Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trial

更正：法瑞西单抗治疗新生血管性年龄相关性黄斑变性患者的疗效、持久性和安全性（每16周一次）：TENAYA III期临床试验日本亚组的1年结果

期刊:Japanese Journal of Ophthalmology
影响因子:1.9
doi:10.1007/s10384-023-00996-7
Mori, Ryusaburo; Honda, Shigeru; Gomi, Fumi; Tsujikawa, Akitaka; Koizumi, Hideki; Ochi, Haruka; Ohsawa, Shino; Okada, Annabelle Ayame
发表日期：2023
文献求助 收藏

Allergic reaction to anisakis-contaminated fish after the first administration of BNT162b2 mRNA vaccine: a case report

首次接种BNT162b2 mRNA疫苗后对异尖线虫污染鱼类产生过敏反应：病例报告

期刊:Gastroenterology Report
影响因子:4.2
doi:10.1093/gastro/goac034
Harada, Fumiue; Yamamoto, Kana; Matsuda, Tomoki; Yamamoto, Chika; Tani, Yuta; Ohnishi, Mutsuko; Takita, Morihito; Tanimoto, Tetsuya; Kami, Masahiro; Shineha, Ryusaburo
发表日期：2022
文献求助 收藏